Skip to main content
. Author manuscript; available in PMC: 2013 Oct 19.
Published in final edited form as: Cancer. 2012 Aug 1;119(3):621–628. doi: 10.1002/cncr.27735

Table 3.

Predicting HPV vaccination (N = 406) with significant bivariate provider factors

Predictor B SE B β t p
Physician ethnicity (non-Hispanic/Latino vs. Hispanic/Latino) −1.69 1.32 −0.06 −1.28 .2015
Family Physician specialty (vs. Pediatrics) −4.98 2.11 −0.11 −2.36 .0188
OBGYN specialty (vs. Pediatrics) −1.06 2.66 −0.03 −0.40 .6902
Multispecialty practice (vs. single specialty) −4.28 1.89 −0.10 −2.26 .0242
Practice other than single or multispecialty (vs. single specialty) −3.54 3.06 −0.05 −1.16 .2473
Practice location (private vs. other) 11.46 1.95 0.28 5.89 <.0001
VFC provider status (no vs. yes) −5.83 2.87 −0.15 −2.03 .0430
VFC provider status (don’t know vs. yes) −10.16 4.00 −0.12 −2.54 .0114
Refer out for HPV vaccination (no vs. yes) 6.00 2.14 0.17 2.80 .0053
Patient race (non-Hispanic White vs. other) −3.97 1.55 −0.11 −2.56 .0109
No strategies used to ensure vaccine completion (vs. 2+ strategies) −5.28 2.17 −0.11 −2.43 .0156
One strategy used to ensure vaccine completion (vs. 2+ strategies) 2.47 1.72 0.06 1.44 .1514
R2 0.32 <.0001

Abbreviations: HPV, human papillomavirus; OBGYN, Obstetrics and Gynecology; VFC, Vaccines for Children.